Management of late, recurrent, and resistant cytomegalovirus in transplant patients

Research output: Contribution to journalReview articlepeer-review

Abstract

The timing and incidence of post-transplant cytomegalovirus (CMV) infections have changed in the era of prophylaxis and preemptive therapy. Late, recurrent, and ganciclovir-resistant CMV syndromes continue to be challenges to clinical management. Recent articles relating to solid-organ transplantation on the topic of CMV occurring after prophylaxis, CMV recurrence, CMV-specific immune reconstitution, and antiviral-resistant CMV were reviewed with particular attention to issues of risk factors, underlying mechanisms, prevention, and management. Recent results from basic research on the cellular immunology and biology of CMV have illuminated clinically observed phenomena related to complex CMV syndromes. Serial measurement of CMV viral load provides valuable information and opportunity for intervention. Although much remains to be learned, current knowledge provides the basis for rational design of CMV prevention and management strategies.

Original languageEnglish (US)
Pages (from-to)65-76
Number of pages12
JournalTransplantation Reviews
Volume21
Issue number2
DOIs
StatePublished - Apr 1 2007
Externally publishedYes

ASJC Scopus subject areas

  • Transplantation

Fingerprint

Dive into the research topics of 'Management of late, recurrent, and resistant cytomegalovirus in transplant patients'. Together they form a unique fingerprint.

Cite this